Clinical Trial Update: CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update exploring CAR-T cell therapy for multiple myeloma, with non-invasive monitoring of biodistribution using BCMA-targeted PET …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA-targeted PET imaging radiotracer
• CAR T cell therapy (investigational) (chimeric antigen receptor T cell therapy)

Snippet

Sponsor: Xuzhou Medical University | Conditions: Non-invasive CAR-T Cell Monitoring, BCMA-targeted PET Imaging | EARLY_Phase 1 | Status: NOT_YET_RECRUITING